DAIVOBET Side Effects

6523191-5 | Adrenal Insufficiency, Cushing's Syndrome, Overdose, Skin Atrophy, Skin Striae
on Dec 07, 2009 Female patient from FRANCE , 27 years of age, was diagnosed with psoriasis and was treated with Daivobet (View Usage). Patient experienced the following unwanted or unexpected effects: adrenal insufficiency, cushing's syndrome, overdose, skin atrophy, skin striae. Daivobet dosage: 60 G Per Day, Topical. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ), ACITRETIN (View Acitretin Review and Acitretin Label ), ETANERCEPT (ETANERCEPT) (View Etanercept (etanercept) Review and Etanercept (etanercept) Label ). Patient was hospitalized.

6438379-1 | Hallucination, Visual
Patient was taking Daivobet (View Usage). Patient had the following side effects: hallucination, visual on Oct 14, 2009 from DENMARK Additional patient health information: Male patient , 31 years of age, was diagnosed with psoriasis and. Daivobet dosage: (1 In 1 D) Topical. During the same period patient was treated with ELCON (MOMETASONE FUROATE) (View Elcon (mometasone Furoate) Review and Elcon (mometasone Furoate) Label ), TAR SHAMPOO (COAL TAR) (View Tar Shampoo (coal Tar) Review and Tar Shampoo (coal Tar) Label ).

6175503-2 | Condition Aggravated, Psoriasis, Suicidal Ideation
Adverse event was reported on Apr 15, 2009 by a Female patient taking Daivobet (View Usage) (Dosage: (2 To 3 Times Per Week) Topical) was diagnosed with psoriasis and. Location: CANADA , 63 years of age, After Daivobet was administered, patient had the following side effects: condition aggravated, psoriasis, suicidal ideation. During the same period patient was treated with LOPRESSOR (View Lopressor Review and Lopressor Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ROCALTROL (View Rocaltrol Review and Rocaltrol Label ).

6147989-0 | Condition Aggravated, Psoriasis, Stress, Suicidal Ideation
on Mar 19, 2009 Female patient from CANADA , 63 years of age, was diagnosed with psoriasis and was treated with Daivobet (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, psoriasis, stress (What is stress?), suicidal ideation. Daivobet dosage: (2 To 3 Times Per Week) Topical. During the same period patient was treated with LOPRESSOR (View Lopressor Review and Lopressor Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ROCALTROL (View Rocaltrol Review and Rocaltrol Label ).


6077949-X | Pharyngeal Oedema
on Jan 26, 2009 Female patient from UNITED KINGDOM , 46 years of age, was treated with Daivobet (View Usage). Patient had the following side effects: pharyngeal oedema. Daivobet dosage: Topical.

5601241-8 | Condition Aggravated, Psoriasis, Skin Exfoliation
Patient was taking Daivobet (View Usage). After Daivobet was administered, patient had the following side effects: condition aggravated, psoriasis, skin exfoliation on Jan 04, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 66 years of age, was diagnosed with psoriasis and. Daivobet dosage: 1 Df (1 Df, 1 In 1 D) Topical. Patient was hospitalized.

5491376-5 | Erythrodermic Psoriasis, Rebound Effect
Adverse event was reported on Oct 02, 2007 by a Female patient taking Daivobet (View Usage) (Dosage: Probably Used More Than 100g Per Week) was diagnosed with psoriasis and. Location: UNITED KINGDOM , 66 years of age, Patient experienced the following unwanted or unexpected effects: erythrodermic psoriasis, rebound effect. During the same period patient was treated with DAIVONEX (CALCIPOTRIOL) (View Daivonex (calcipotriol) Review and Daivonex (calcipotriol) Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.

5363355-X | Adrenal Insufficiency, Cushing's Syndrome, Cytolytic Hepatitis, Diabetes Mellitus Non-insulin-dependent, Guttate Psoriasis, Skin Atrophy
on May 31, 2007 Male patient from FRANCE , 50 years of age, was diagnosed with psoriasis and was treated with Daivobet (View Usage). Patient had the following side effects: adrenal insufficiency, cushing's syndrome, cytolytic hepatitis, diabetes mellitus non-insulin-dependent, guttate psoriasis, skin atrophy. Daivobet dosage: 4 To 5 Tubes Per Month, Topical. During the same period patient was treated with SORIATANE (View Soriatane Review and Soriatane Label ), SYNALAR GRAS (FLUOCINOLONE ACETONIDE) (5 Tubes Per Month, Topical) (View Synalar Gras (fluocinolone Acetonide) Review and Synalar Gras (fluocinolone Acetonide) Label ), NERISALIC (NERISALIC) (2 Tubes Per Month On Scalp, Topical) (View Nerisalic (nerisalic) Review and Nerisalic (nerisalic) Label ). Patient was hospitalized.

5341696-X | Acute Pulmonary Oedema, Streptococcal Sepsis
on May 14, 2007 Female patient from FRANCE , 80 years of age, was diagnosed with psoriasis and was treated with Daivobet (View Usage). After Daivobet was administered, patient had the following side effects: acute pulmonary oedema, streptococcal sepsis. Daivobet dosage: 2 Tubes Applied. Patient was hospitalized.

5196034-2 | Abortion Induced, Skull Malformation
Patient was taking Daivobet (View Usage). Patient experienced the following unwanted or unexpected effects: abortion induced, skull malformation on Dec 12, 2006 from FRANCE Additional patient health information: Female patient , 24 years of age, was diagnosed with psoriasis and. Daivobet dosage: To.

5091939-5 | Acute Respiratory Distress Syndrome, Enterococcal Infection, Pustular Psoriasis, Staphylococcal Infection
Adverse event was reported on Aug 10, 2006 by a Female patient taking Daivobet (View Usage) (Dosage: 2 Application (1 Application, 2 In 1 D) To) was diagnosed with psoriasis and. Location: UNITED KINGDOM , 49 years of age, Patient had the following side effects: acute respiratory distress syndrome, enterococcal infection, pustular psoriasis, staphylococcal infection (What is staphylococcal infection?). During the same period patient was treated with APOMORPHINE (View Apomorphine Review and Apomorphine Label ), CABERGOLINE (View Cabergoline Review and Cabergoline Label ), FLUCLOXACILLIN (View Flucloxacillin Review and Flucloxacillin Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ). Patient was hospitalized and became disabled.

5042356-5 | Arthralgia, Overdose, Pain Of Skin, Pigmentation Disorder, Pustular Psoriasis, Pyrexia, Rebound Effect
on Jun 13, 2006 Male patient from FRANCE , child 11 years of age, weighting 57.32 lb, was diagnosed with psoriasis and was treated with Daivobet (View Usage). After Daivobet was administered, patient had the following side effects: arthralgia, overdose, pain of skin, pigmentation disorder, pustular psoriasis, pyrexia, rebound effect. Daivobet dosage: 1 Application. During the same period patient was treated with NERISALIC (NERISALIC) (View Nerisalic (nerisalic) Review and Nerisalic (nerisalic) Label ), SAUGELLA (View Saugella Review and Saugella Label ). Patient was hospitalized.

5023215-0 | Arthralgia, Overdose, Pain Of Skin, Pustular Psoriasis, Pyrexia, Rebound Effect
on May 23, 2006 Male patient from FRANCE , child 11 years of age, was diagnosed with psoriasis and was treated with Daivobet (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, overdose, pain of skin, pustular psoriasis, pyrexia, rebound effect. Daivobet dosage: 1 Application To. During the same period patient was treated with NERISALIC (NERISALIC) (View Nerisalic (nerisalic) Review and Nerisalic (nerisalic) Label ), SAUGELLA (View Saugella Review and Saugella Label ). Patient was hospitalized.